Abstract:Objectives To compare the outcomes among patients treated by complete coronary revascularization (CCR) or incomplete coronary revascularization (ICR) and no coronary revascularization (NCR) by myocardial perfusion imaging (MPI), as well as to evaluate the impact of severity of ischemia on patients with coronary artery disease (CAD) by different therapy strategies. Background Using myocardial ischemia severity determined by MPI guiding treatment strategies for CAD patients still lacks strong clinical evidences. Methods Consecutive patients (N = 286) underwent clinical stress-rest SPECT MPI and were retrospectively followed-up. For assessment of outcome of treatment, all patients were classified into three groups (CCR, ICR, and NCR), and further divided into two subgroups as mild ischemia (< 10% ischemic myocardium) and moderate-severe ischemia (≥ 10% ischemic myocardium). All-cause death was defined as the primary endpoint, and the composite of deaths, nonfatal myocardial infarction, and repeat revascularization (MACE) as the secondary endpoint. Results Two-hundred eighty-six patients were followed-up for 46 ± 21 months. Thirty deaths and 65 MACEs were recorded. Patients treated by revascularization had significantly lower MACE ( P < .001) but not mortality ( P = .158) than patients treated by NCR. Outcomes of CCR related to mortality rate were greater than ICR and NCR (death: P = .019, MACE: P < .001). In patients with moderate-severe ischemia, CCR showed improved outcomes than ICR and NCR (death: P = .034; and MACE: P < .001). In patients with mild ischemia, the outcomes of CCR, ICR, and NCR had no significant difference ( P > .05). Multivariate regression Cox analysis revealed that summed difference score [death: HR 1.09 (1.03, 1.15), P = .004] was an independent risk factor and CCR was an independent negative predictor [death: HR 0.31 (0.12, 0.81), P = .017; MACE: HR 0.30 (0.16, 0.57), P < .001]. Conclusions Outcomes of patients treated by CCR were most likely more promising in comparison with treatment of ICR and NCR, especially when patients had over 10% ischemic myocardium.

Infarct-related artery only revascularization versus multi-vessel revascularization for patients with Killip I-IV acute myocardial infarction and multivessel disease

Study of intravenous thrombolysis with recombinant tissue plasminogen activator(rtPA)in isolatedpenetrating artery territory infarcts

Comparative Effects Of Percutaneous Coronary Intervention For Infarct-Related Artery Only Or For Both Infarct- And Non-Infarct-Related Arteries In Patients With St-Elevation Myocardial Infarction And Multi-Vessel Disease

Complete Revascularization Versus Culprit-Only Revascularization in ST-segment Elevation Myocardial Infarction and Multivessel Disease Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis and Trial Sequential Analysis

Long-term outcome of acute myocardial infarction patients with early percutaneous coronary intervention to non-culprit vessels

Complete revascularisation versus culprit lesion only PCI in patients with non-ST-elevation myocardial infarction and multivessel disease.

Thirty-day Outcomes of In-Hospital Multi-Vessel Versus Culprit-Only Revascularization Strategy for ST-segment Elevation Myocardial Infarction with Multivessel Coronary Disease.

Complete Revascularization Based on Angiography Derived Fractional Flow Reserve Versus Incomplete Revascularization in Patients with ST-segment Elevation Myocardial Infarction.

Revascularization Strategy in Myocardial Infarction with Multivessel Disease

Impact of Immediate Versus Staged Complete Revascularization on Short-Term and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome and Multivessel Disease: A Systematic Review and Meta-Analysis

Optional Revascularization Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease

Immediate vs. multistage revascularization of non-infarct coronary artery(-ies) in patients with hemodynamically stable multivessel disease acute myocardial infarction: a systematic review and meta-analysis

Impact of different strategies of complete percutaneous revascularization on prognosis of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease

Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization

Acute coronary syndrome revascularization strategies with multi-vessel coronary artery disease

Abstract WP140: Perfusion Collateral Index Predicts Infarct Growth in Successfully Reperfused Patients With Acute Ischemic Stroke

Impact for Incomplete Correction of Myocardial Ischemia on Long-term Prognosis in Patients With Revascularization

The efficacy and safety of quantitative flow ratio-guided complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A pilot randomized controlled trial

Short- and Long-Term Outcomes in Patients With Right Ventricular Infarction According to Modalities of Reperfusion Strategies in China: Data From China Acute Myocardial Infarction Registry

Impact Of Revascularization In Patients With Post-Infarction Left Ventricular Aneurysm And Ventricular Tachyarrhythmia

Cardiogenic shock complicating acute myocardial infarction and multivessel disease: revascularization strategy according to ischemic territory